Skip to main content
CellaVision logo

CellaVision — Investor Relations & Filings

Ticker · CEVI ISIN · SE0000683484 LEI · 529900IUBZBZ0HXFJ114 ST Manufacturing
Filings indexed 388 across all filing types
Latest filing 2017-10-25 Interim / Quarterly Rep…
Country SE Sweden
Listing ST CEVI

About CellaVision

https://www.cellavision.com/

CellaVision is a medical technology company that provides digital solutions for cell morphology in hematology. The company specializes in automating and standardizing the analysis of blood and other body fluids for both human and veterinary applications. Its core offerings include a complete system of analyzers, instruments, software, and reagents designed for hematology laboratories of all sizes. By utilizing patented technology that integrates automated microscopy, advanced image analysis, and artificial intelligence, CellaVision's systems digitize the traditional manual review of blood smears. This automation enhances laboratory workflow efficiency, improves diagnostic accuracy, and facilitates remote collaboration among healthcare professionals, advancing diagnostic certainty.

Recent filings

Filing Released Lang Actions
Interim / Quarterly Report 2017
Interim / Quarterly Report Classification · 1% confidence The document is titled 'Interim report January-September 2017' and contains detailed financial statements, including net sales, operating profit, cash flow, and balance sheet data for the specified period. It provides a comprehensive analysis of business performance, geographical market development, and research and development activities. It is not an announcement of a report, but the report itself, and it covers a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report. 9M 2017
2017-10-25 English
Interim / Quarterly Report 2017
Interim / Quarterly Report Classification · 1% confidence The document is a 'Delårsrapport' (Interim Report) for the period January-June 2017. It contains comprehensive financial statements, including income statements, balance sheets, cash flow data, and detailed management commentary on market performance, R&D, and regional analysis. It is clearly a substantive financial report rather than a mere announcement or certification, fitting the definition of an Interim/Quarterly Report (IR). H1 2017
2017-07-18 Swedish
Interim / Quarterly Report 2017
Interim / Quarterly Report Classification · 1% confidence The document is explicitly titled 'Interim report January-June 2017' and contains comprehensive financial statements, key ratios, management commentary, and segment reporting for the period. It meets the criteria for an Interim/Quarterly Report (IR) as it provides substantive financial data and analysis for a period shorter than a full fiscal year. Q2 2017
2017-07-18 English
Major Shareholding Notification 2017
Major Shareholding Notification Classification · 1% confidence The document details a change in shareholding ('Holder: Christer Fåhraeus') involving a 'Sell' transaction, resulting in a new total share count and percentage. The structure explicitly mentions 'Reason for major shareholding notification Sell' and provides before/after transaction details regarding shares and voting rights. This directly corresponds to the definition of a Major Shareholding Notification (MRQ), which covers changes in significant share ownership levels crossing thresholds.
2017-05-24 English
CellaVision AB: Kommuniké från årsstämma i CellaVision AB (publ) den 5 maj 2017
AGM Information Classification · 1% confidence The document is explicitly titled "Kommuniké från årsstämma i CellaVision AB (publ) den 5 maj 2017" (Communiqué from the Annual General Meeting in CellaVision AB (publ) on May 5, 2017). It details decisions made regarding dividend distribution, approval of discharge for management, election of the board and auditor, and remuneration. These are core activities of an Annual General Meeting (AGM). Although it is a communiqué summarizing the event rather than the full presentation slides, the content directly relates to the outcomes of the AGM. Therefore, the most appropriate classification is AGM Information (AGM-R).
2017-05-05 Swedish
CellaVision AB: Bulletin from the Annual General Meeting of CellaVision AB (publ) held on May 5, 2017
AGM Information Classification · 1% confidence The document is explicitly titled "Bulletin from the Annual General Meeting of CellaVision AB (publ) held on May 5, 2017." It details resolutions passed at the meeting, including dividend payments, discharge from liability, and re-election of board members. This content directly corresponds to the definition of AGM Information. Although it mentions the CEO's address is available elsewhere, the primary content is the summary of AGM resolutions.
2017-05-05 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.